REZCUE
REZCUE: Mucosal Protection During NSAID Use
NSAIDs damage the gut through two separate mechanisms: prostaglandin-mediated loss of mucosal defences (acid-driven, addressed by PPIs) and direct cytotoxic injury to the small intestine (acid-inde...
Case Studies
Zinc L-Carnosine and Atrophic Gastritis: What a New Case Series Actually Shows
A November 2025 case series reported that two patients with chronic atrophic gastritis (CAG) — one post-H. pylori, one autoimmune — showed histological improvement after 12 months on zinc L-carnosi...
REZCUE
REZCUE — Clinical Application Protocols and Intervention Dosing
This article is based on our REZCUE white paper which you can download here.
REZCUE combines two well-researched gut mucosal agents: pharmaceutical-grade Zinc L-Carnosine (37.5mg per scoop) and L...
Clinical Information
Selecting and Combining THERA Nordic Products — A Clinical Reference
For healthcare professionals. This content is intended for practitioners only.
This article provides a clinical reference for the THERA Nordic product range, covering the primary indication and me...